InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
T+90 hit rate
0%
T+90 mean return
-20.5%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Ciulla Thomas, Directeur Médical. Officer active across 1 company, notably Clearside Biomedical, Inc.. Cumulatively, 9 reports have been recorded. Split: 0 buy · 4 sells. Total volume traded: €50k. Activity tracked since 21 September 2021. The latest transaction was disclosed on 20 January 2023 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
13,700 shares@ US$1.4733.3% of flowCommon StockSEC:0001209191-23-004278:0
2,170 shares@ US$1.625.9% of flowCommon StockSEC:0001209191-23-002993:0
5,000 shares@ US$1.2510.7% of flowCommon StockSEC:0001209191-23-002341:0
46,250 shares0Common StockSEC:0001209191-22-005440:0
46,250 shares0Common StockSEC:0001209191-22-005440
43,750 shares0Common StockSEC:0001209191-22-004193
43,750 shares0Common StockSEC:0001209191-22-004193:0
2,560 shares@ US$6.400.019% mcap50.0% of flowCommon StockSEC:0001209191-21-057461:0
2,560 shares@ US$6.4025.1% of flowCommon StockSEC:0001209191-21-057461
9 of 9 declarations
About Ciulla Thomas
Thomas Ciulla is the Chief Medical Officer at Clearside Biomedical, Inc. He is responsible for the medical direction and product development strategy. Thomas leverages his expertise to guide clinical initiatives and ensure the safety and efficacy of the treatments offered by the company.
